These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26712820)

  • 41. Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.
    Pfeifer ND; Harris KB; Yan GZ; Brouwer KL
    Drug Metab Dispos; 2013 Nov; 41(11):1949-56. PubMed ID: 23990525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment with atazanavir and lopinavir/ritonavir combination therapy in protease inhibitor-susceptible and protease inhibitor-resistant HIV-infected patients.
    Gilliam BL; Chan-Tack KM; Qaqish RB; Rode RA; Fantry LE; Redfield RR
    AIDS Patient Care STDS; 2006 Nov; 20(11):745-59. PubMed ID: 17134349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L; Bundgaard C; Garmer M; Jensen B
    Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of carrier-mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes.
    Iwakiri T; Okumura M; Hidaka M; Kumagai Y; Ichihara E; Kawano Y; Arimori K
    J Appl Toxicol; 2008 Apr; 28(3):329-36. PubMed ID: 17604344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems.
    Lau YY; Okochi H; Huang Y; Benet LZ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):762-71. PubMed ID: 16258024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resolving the distribution-metabolism interplay of eight OATP substrates in the standard clearance assay with suspended human cryopreserved hepatocytes.
    Nordell P; Winiwarter S; Hilgendorf C
    Mol Pharm; 2013 Dec; 10(12):4443-51. PubMed ID: 24102095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells.
    Roucairol C; Azoulay S; Nevers MC; Créminon C; Lavrut T; Garraffo R; Grassi J; Burger A; Duval D
    Antimicrob Agents Chemother; 2007 Feb; 51(2):405-11. PubMed ID: 17116661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.
    Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS
    Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of the H+/organic cation antiporter in nicotine transport in rat liver.
    Tega Y; Akanuma S; Kubo Y; Hosoya K
    Drug Metab Dispos; 2015 Jan; 43(1):89-92. PubMed ID: 25352656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting metabolic clearance for drugs that are actively transported into hepatocytes: incubational binding as a consequence of in vitro hepatocyte concentration is a key factor.
    Nordell P; Svanberg P; Bird J; Grime K
    Drug Metab Dispos; 2013 Apr; 41(4):836-43. PubMed ID: 23364509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat.
    Treiber A; Schneiter R; Delahaye S; Clozel M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1121-9. PubMed ID: 14617681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
    Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
    Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.
    Gianotti N; Seminari E; Guffanti M; Boeri E; Villani P; Regazzi M; Bigoloni A; Schira G; Tiberi S; Fusetti G; Lazzarin A; Castagna A
    New Microbiol; 2005 Apr; 28(2):119-25. PubMed ID: 16035256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations.
    Smith DE; Jeganathan S; Ray J
    HIV Clin Trials; 2006; 7(1):34-8. PubMed ID: 16632461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytes.
    Grime K; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2008 Aug; 36(8):1670-8. PubMed ID: 18474678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.
    Kulkarni P; Korzekwa K; Nagar S
    J Pharmacol Exp Ther; 2016 Oct; 359(1):26-36. PubMed ID: 27451408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system.
    Omori H; Chikamoto J; Nagahara M; Hirata M; Otoi T
    Toxicol In Vitro; 2023 Dec; 93():105689. PubMed ID: 37660998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of in vivo tissue distribution from in vitro data. 2. Influence of albumin diffusion from tissue pieces during an in vitro incubation on estimated tissue-to-unbound plasma partition coefficients (Kpu).
    Ballard P; Arundel PA; Leahy DE; Rowland M
    Pharm Res; 2003 Jun; 20(6):857-63. PubMed ID: 12817888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.